Skip to main content

Table 1 Clinical-pathological characteristics of goiter and patients of Group 1 – no sternotomy (n = 40 patients) and Group 2 – associated sternotomy (n = 4 patients)

From: Thyroiditis process as a predictive factor of sternotomy in the treatment of cervico-mediastinal goiter

   Group 1
(n = 40)
Group 2
(n = 4)
p
Age years (medium ± SD) 58,63 ± 9,67 67,5 ± 4,36 0,075
(range) (39–79) (64–73)
fT4 ng/dL (medium ± SD) 9,45 ± 2,09 6,52 ± 3,78 0,068
(range) (2,0 - 14,3) (0,9 - 9,0)
TSH mUI/L (medium ± SD) 1,45 ± 2,27 1,32 ± 0,73 0,515
(range) (0,073 - 13,62) (0,278 - 1,97)
Presence of goiter years (medium ± SD) 8,40 ± 4,27 14,75 ± 1,89 0,008
(range) (3–20) (12–16)
Thyroid’s weight gr (medium ± SD) 127,00 ± 73,18 227,00 ± 32,19 0,02
(range) (45–385) (193–257)
Post-operative serum calcium mg/dL (medium ± SD) 8,39 ± 0,67 9,17 ± 0,84 0,169
(range) (7,4 - 10,7) (8,2 - 9,7)
PTH pg/mL (medium ± SD) 18,74 ± 27,47 15,50 ± 12,38 0,875
(range) (1,3 - 140,0) (1,5 - 25,0)
Presence of symptoms yes (%) 23 (57,5%) 3 (75,0%) 0,455
not (%) 17 (42,5%) 1 (25,0%)
Extension to the aortic arch above (%) 40 (100%) 1 (25,0%) 0,0001
below (%) 0 (0%) 3 (75,0%)
Lateral extension of goiter right (%) 11 (27,5%) 1 (25,0%) 0,583
left (%) 25 (62,5%) 2 (50,0%)
bilateral (%) 4 (10,0%) 1 (25,0%)
Histological malignancy yes (%) 6 (15,0%) 1 (25,0%) 0,513
not (%) 34 (85,0%) 3 (75,0%)
Histological thyroiditis yes (%) 6 (15,0%) 3 (75,0%) 0,023
not (%) 34 (85,0%) 1 (25,0%)